Literature DB >> 2783306

Pathogenesis of emphysema. Assessment of basic science concepts through clinical investigation.

M Wewers1.   

Abstract

It is clear that alpha 1AT deficiency leads to early onset pulmonary emphysema. With the lead provided by the deficiency state, studies aimed at the linkage between alpha 1AT and its target enzyme, neutrophil elastase, have provided useful information about the pathogenesis of emphysema due to cigarette smoking. alpha 1AT represents the predominant antielastase of the lower respiratory tract. This observation implicates neutrophil elastase as the enzyme responsible for lung destruction, since affinity studies demonstrate that alpha 1ATs physiologically relevant function is the inhibition of neutrophil elastase. However, because of the inexorably slow nature of the emphysema process, demonstration of the protease-antiprotease imbalance in the lungs of smokers has been difficult. Studies using sensitive assays for alpha 1AT function and for neutrophil elastase's presence have added new support for the protease-antiprotease theory, and evaluation of related disorders such as the adult respiratory distress syndrome and cystic fibrosis have provided corraborative evidence. Finally, studies that have indicated that the major site of the protease-antiprotease imbalance is the microenvironment of protease-producing cells offer a new direction for future research into the pathogenesis of emphysema.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783306     DOI: 10.1378/chest.95.1.190

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 2.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.

Authors:  R A Stockley; D Bayley; S L Hill; A T Hill; S Crooks; E J Campbell
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

4.  Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate.

Authors:  A Rudolphus; J Stolk; C van Twisk; C J van Noorden; J H Dijkman; J A Kramps
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon.

Authors:  S D Shapiro; S K Endicott; M A Province; J A Pierce; E J Campbell
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 6.  Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 7.  Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment.

Authors:  M Hussain; G Mieli-Vergani; A P Mowat
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

8.  Use of elastin fibre detection in the diagnosis of ventilator associated pneumonia.

Authors:  M el-Ebiary; A Torres; J González; A Martos; J Puig de la Bellacasa; M Ferrer; R Rodriguez-Roisin
Journal:  Thorax       Date:  1995-01       Impact factor: 9.139

Review 9.  Alpha 1-antitrypsin deficiency and liver disease.

Authors:  P Birrer; N G McElvaney; L M Chang-Stroman; R G Crystal
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Alpha1-antitrypsin deficiency: a clinical-genetic overview.

Authors:  Raja T Abboud; Tanya N Nelson; Benjamin Jung; Andre Mattman
Journal:  Appl Clin Genet       Date:  2011-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.